Digital Health Research & Clinical Audits (The "Brain" Service)

At Health Management IQ, we provide independent clinical audits and Real-World Evidence (RWE) research that bridges the gap between digital innovation and clinical adoption. We evaluate how Digital Health Technologies (DHTs) perform in complex, real-world settings, providing Integrated Care Boards (ICBs) and global innovators with the data required to justify long-term funding and satisfy NICE 2026 evidence standards.

 

As the UK moves toward a "rules-based" prescribing model, a significant challenge in the current digital shift is the "evidence gap" where digital tools are often tested in controlled environments that do not reflect the diversity of the UK population. 

 

​Our proprietary inclusive Practice Research Network (PRN).

We have developed a trusted, secure infrastructure for gathering insights from populations that are historically "seldom-heard" in clinical trials. By conducting audits through our specialised community led hubs, we provide funders and researchers with high resolution data on user engagement, medication adherence, and health outcomes in marginalised and deprived areas addressing the Core20PLUS5 mandate at its core.

​​

For ICBs and transformation managers we serve as a strategic audit partner for the NHS Digital Front Door. We can help move beyond basic usage metrics to provide deep-dive analysis into how digital interventions actively reduce secondary care waiting lists and improve long-term condition management, such as CVD and Diabetes. Our independent audits provide the clinical assurance needed for commissioners to scale from small short term pilots to sustainable, nationally-reimbursed digital care pathways with total confidence.

​​

For medtech innovators and developers, we provide the critical feedback loop necessary to achieve DTAC compliance and NICE Early Value Assessment (EVA) success. By partnering with Health Management IQ, you are investing in turning raw data into the "Gold Standard" evidence required to secure a place on the national prescription list and achieve lasting clinical impact.

 

We invite universities, and life science organisations to partner with us. We can build a future with digital health, ensuring that as the NHS modernises, the health outcomes of the most vulnerable are prioritised and protected.